On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€304k · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- BERENICEPartner
Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€173ktheir share - FAST-XDR-DETECTPartner
Development of a two-approach plate system for the fast and simultaneous detection of MDR and XDR M. tuberculosis
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€131ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universitat de BarcelonaSpain · 1 shared project
- Universidade Nova de LisboaPortugal · 1 shared project
- Helmholtz-Zentrum Fur Infektionsforschung GmbHGermany · 1 shared project
- Instituut Voor Tropische GeneeskundeBelgium · 1 shared project
- Consorcio Centro de Investigacion Biomedica en Red M.p.Spain · 1 shared project
- Institut Catala de la SalutSpain · 1 shared project
- Fundacao Oswaldo CruzBrazil · 1 shared project
- Lionex GmbHGermany · 1 shared project
- Biokeralty Research Institute AieSpain · 1 shared project
- SmittskyddsinstitutetSweden · 1 shared project
- Corporacion CorpogenColombia · 1 shared project
- Instituto de Higiene e Medicina TropicalPortugal · 1 shared project
- Centro de Investigacion Biomedica en Red Bioingenieria, Biomateriales y NanomedicinaSpain · 1 shared project
- Latvijas Infektologijas Centrs (Infectology Center of Latvia)Latvia · 1 shared project
- Hospital Zonal Especializado de Agudos y Cronicos Dr. CetrangoloArgentina · 1 shared project
- Laboratorio Elea Sociedad Anonima Comercial, Industrial, Financiera y AgropecuariaArgentina · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- HIV
- multidrug resistance
- nanomedicine
- pharmaceutical drugs
- pharmacokinetics
- tuberculosis
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗